Special Issue "Functional Nanohybrids for Drug Delivery"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: 30 January 2019
Nanomaterial-based drug delivery systems have been seen as a publicly-known strategy to improve therapeutic efficacy in cancer therapies. However, dense extracellular matrix and interstitial fluid pressure in the tumor suppress deep delivery and lead to inhomogeneous treatments. Not only able to accumulate at highly permeable peripheral blood vessels via enhanced permeability and retention (EPR) effects, nanohybrids should also be concerned with different functions to enhance drug delivery. Stimuli-response and functions of nanohybrids are two impressive manipulations for enhanced drug delivery. In addition, targeting moiety for specific diseases also shelters the mononuclear phagocyte system and promotes enhanced delivery. Therefore, after drug injection, obstacles from blood circulation, tumor accumulation, and penetrated delivery should be comprehensively considered, and thus multifunctional nanohybrids will be the ideal platforms for enhanced drug delivery. The development of new nanohybrids represents an important step in the field of drug delivery systems.
This Special Issue has the aim of highlighting current progress in the use of the multifunctional nanohybrids for enhanced drug delivery.Prof. Shang-Hsiu Hu
Prof. Chien-Wen Chang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Drug delivery
- Cancer therapy
- Functional materials
- Triggered release
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Author: V. Camacho, M. L. Moyá, M. López-López, A. Sánchez, F. J. Ostos, J.A. Lebrón, V. Merino, M. Camean, M. A. Callejas, P. López-Cornejo
Title: Systematic study on the encapsulation of levofloxacin by nanoparticles for drug delivery
Author: M. López-López, M. L. Moyá, A. Fernández-Delgado, D. Blanco-Arévalo, R.R. de la Haba, C. Carrera-Sánchez, A. Ventosa, P. López-Cornejo